Vimarsana
Biggest News Aggregation in the World

Nanoly Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nanoly Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nanoly Bioscience Today - Breaking & Trending Today

Global Hydrogels Market Research Report 2022: Key Markets, Hydrogel Revenues, Key Growth Areas, Opportunities and Demand 2020-2033 - Vimarsana News

Global Hydrogels Market Research Report 2022: Key Markets, Hydrogel Revenues, Key Growth Areas, Opportunities and Demand 2020-2033

/PRNewswire/ -- The "The Global Market for Hydrogels 2023-2033" report has been added to ResearchAndMarkets.com's offering. In recent years, development of...

Global Hydrogels Market Research Report 2022: Key Markets, Hydrogel Revenues, Key Growth Areas, Opportunities and Demand 2020-2033 - Vimarsana News

Global Hydrogels Market Research Report 2022: Key Markets, Hydrogel Revenues, Key Growth Areas, Opportunities and Demand 2020-2033

/PRNewswire/ -- The "The Global Market for Hydrogels 2023-2033" report has been added to ResearchAndMarkets.com's offering. In recent years, development of...

Hydrogel could ease need for vaccine 'cold chain' - Vimarsana News

Hydrogel could ease need for vaccine 'cold chain'

The need to keep vaccines cold makes global shipping a challenge. Researchers say their hydrogel approach could change that.

Hydrogel Extends Shelf Life of Vaccines - Vimarsana News

Hydrogel Extends Shelf Life of Vaccines

Vaccine distribution faces big challenges, as the COVID crisis has shown. Now, a multidisciplinary research team has overcome some of the major issues that plague the distribution of biomedical materials.

Source: azom.com
Kindred Biosciences Announces Two New Appointments to Board of Directors - Vimarsana News

Kindred Biosciences Announces Two New Appointments to Board of Directors

Kindred Biosciences Announces Two New Appointments to Board of Directors News provided by Share this article Share this article SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has appointed Lyndon Lien, Ph.D., an experienced biotech CEO, entrepreneur and investor, and Nanxi Liu, CEO and Co-Founder of Enplug and Co-Founder of Nanoly Bioscience, to its Board of Directors, effective February 5, 2021. "We are very pleased to welcome Lyndon and Nanxi to our Bo...